메뉴 건너뛰기




Volumn 40, Issue 7, 2014, Pages 891-898

Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: A multicenter study

Author keywords

Epithelial ovarian cancer; Isolated lymph node recurrence; Secondary cytoreductive surgery

Indexed keywords

CARBOPLATIN; DOXORUBICIN; PACLITAXEL;

EID: 84901481831     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.11.026     Document Type: Article
Times cited : (33)

References (34)
  • 1
    • 80055122337 scopus 로고    scopus 로고
    • Optimal primary surgical treatment for advanced epithelial ovarian cancer
    • A. Elattar, A. Bryant, and B.A. Winter-Roach et al. Optimal primary surgical treatment for advanced epithelial ovarian cancer Cochrane Database Syst Rev 10 8 2011 Aug
    • (2011) Cochrane Database Syst Rev , vol.10 , Issue.8
    • Elattar, A.1    Bryant, A.2    Winter-Roach, B.A.3
  • 2
    • 80053623186 scopus 로고    scopus 로고
    • Prognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: A retrospective study of 108 cases
    • J.M. Classe, I. Jaffre, and J.S. Frenel et al. Prognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: a retrospective study of 108 cases Eur J Surg Oncol 2011 971 977
    • (2011) Eur J Surg Oncol , pp. 971-977
    • Classe, J.M.1    Jaffre, I.2    Frenel, J.S.3
  • 4
    • 57649083923 scopus 로고    scopus 로고
    • Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
    • R.E. Bristow, I. Puri, and D.S. Chi Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis Gynecol Oncol 112 2009 256 274
    • (2009) Gynecol Oncol , vol.112 , pp. 256-274
    • Bristow, R.E.1    Puri, I.2    Chi, D.S.3
  • 6
    • 84858232676 scopus 로고    scopus 로고
    • Extraperitoneal metastases from recurrent ovarian cancer
    • W.R. Robinson, J. Beyer, and S. Griffin et al. Extraperitoneal metastases from recurrent ovarian cancer Int J Gynecol Cancer 22 2012 43 46
    • (2012) Int J Gynecol Cancer , vol.22 , pp. 43-46
    • Robinson, W.R.1    Beyer, J.2    Griffin, S.3
  • 7
    • 33846018958 scopus 로고    scopus 로고
    • Isolated lymph node relapse of epithelial ovarian carcinoma: Outcomes and prognostic factors
    • P. Blanchard, A. Plantade, and C. Pages et al. Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors Gynecol Oncol 104 2007 41 45
    • (2007) Gynecol Oncol , vol.104 , pp. 41-45
    • Blanchard, P.1    Plantade, A.2    Pages, C.3
  • 8
    • 61349116871 scopus 로고    scopus 로고
    • Epithelial ovarian cancer relapsing as isolated lymph node disease: Natural history and clinical outcome
    • F. Legge, M. Petrillo, and V. Adamo et al. Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome BMC Cancer 8 2008 367
    • (2008) BMC Cancer , vol.8 , pp. 367
    • Legge, F.1    Petrillo, M.2    Adamo, V.3
  • 9
    • 0043167991 scopus 로고    scopus 로고
    • Lymph node involvement in epithelial ovarian cancer: Analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications
    • P. Morice, F. Joulie, and S. Camatte et al. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications J Am Coll Surg 197 2003 198 205
    • (2003) J Am Coll Surg , vol.197 , pp. 198-205
    • Morice, P.1    Joulie, F.2    Camatte, S.3
  • 10
    • 0000335247 scopus 로고
    • FIGO staging of ovarian cancer. from FIGO Cancer Committee Staging Announcement
    • FIGO staging of ovarian cancer. From FIGO Cancer Committee Staging Announcement Gynecol Oncol 25 1986 383 385
    • (1986) Gynecol Oncol , vol.25 , pp. 383-385
  • 11
    • 77957568499 scopus 로고    scopus 로고
    • The impact of systematic para-aortic and pelvic lymphadenectomy on survival in patients with optimally debulked ovarian cancer
    • A. Abe, A. Furumoto, and Irahara et al. The impact of systematic para-aortic and pelvic lymphadenectomy on survival in patients with optimally debulked ovarian cancer J Obstet Gynaecol Res 36 5 2010 Oct 1023 1030
    • (2010) J Obstet Gynaecol Res , vol.36 , Issue.5 , pp. 1023-1030
    • Abe, A.1    Furumoto, A.2    Irahara3
  • 12
    • 34748902355 scopus 로고    scopus 로고
    • Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B
    • G. Ferrandina, G. Scambia, and F. Legge et al. Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B Gynecol Oncol 107 2007 154 156
    • (2007) Gynecol Oncol , vol.107 , pp. 154-156
    • Ferrandina, G.1    Scambia, G.2    Legge, F.3
  • 13
    • 33751433344 scopus 로고    scopus 로고
    • Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?
    • W.A. Cliby, G.D. Aletti, and T.O. Wilson et al. Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol 103 2006 797 801
    • (2006) Gynecol Oncol , vol.103 , pp. 797-801
    • Cliby, W.A.1    Aletti, G.D.2    Wilson, T.O.3
  • 14
    • 0037440295 scopus 로고    scopus 로고
    • Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm trial
    • European Organisation for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm
    • J.B. Trimbos, I. Vergote, G. Bolis European Organisation for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm trial J Natl Cancer Inst 95 2003 113 125
    • (2003) J Natl Cancer Inst , vol.95 , pp. 113-125
    • Trimbos, J.B.1    Vergote, I.2    Bolis, G.3
  • 15
    • 20244376152 scopus 로고    scopus 로고
    • Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial
    • P. Benedetti Panici, A. Maggioni, and N. Hacker et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial J Natl Cancer Inst 97 2005 560 566
    • (2005) J Natl Cancer Inst , vol.97 , pp. 560-566
    • Benedetti Panici, P.1    Maggioni, A.2    Hacker, N.3
  • 16
    • 33644845467 scopus 로고    scopus 로고
    • Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 trial
    • S.C. Crawford, P.A. Vasey, and J. Paul et al. Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 trial J Clin Oncol 23 2005 8802 8811
    • (2005) J Clin Oncol , vol.23 , pp. 8802-8811
    • Crawford, S.C.1    Vasey, P.A.2    Paul, J.3
  • 17
    • 35948966883 scopus 로고    scopus 로고
    • The role of lymphadenectomy in advanced epithelial ovarian cancer in patients with macroscopically complete resection of intraperitoneal disease
    • A. Du Bois, A. Reuss, and P. Harter The role of lymphadenectomy in advanced epithelial ovarian cancer in patients with macroscopically complete resection of intraperitoneal disease Int J Gynecol Cancer 16 S3 2006 599 615
    • (2006) Int J Gynecol Cancer , vol.16 , Issue.3 , pp. 599-615
    • Du Bois, A.1    Reuss, A.2    Harter, P.3
  • 18
    • 0020574567 scopus 로고
    • Survival of patients following secondary cytoreductive surgery in ovarian cancer
    • J.S. Berek, N.F. Hacker, and L.D. Lagasse Survival of patients following secondary cytoreductive surgery in ovarian cancer Obstet Gynecol 61 1983 189 193
    • (1983) Obstet Gynecol , vol.61 , pp. 189-193
    • Berek, J.S.1    Hacker, N.F.2    Lagasse, L.D.3
  • 19
    • 0028786870 scopus 로고
    • Secondary cytoreductive surgery for recurrent ovarian cancer: A prospective study
    • S.M. Eisenkop, R.L. Friedman, and H.J. Wang Secondary cytoreductive surgery for recurrent ovarian cancer: a prospective study Cancer 76 1995 1606 1614
    • (1995) Cancer , vol.76 , pp. 1606-1614
    • Eisenkop, S.M.1    Friedman, R.L.2    Wang, H.J.3
  • 20
    • 34548130199 scopus 로고    scopus 로고
    • Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma
    • S.J. Tebes, R.A. Sayer, and J.M. Palmer et al. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma Gynecol Oncol 106 2007 482 487
    • (2007) Gynecol Oncol , vol.106 , pp. 482-487
    • Tebes, S.J.1    Sayer, R.A.2    Palmer, J.M.3
  • 21
    • 34250223484 scopus 로고    scopus 로고
    • Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer
    • P. Benedetti Panici, A. De Vivo, and F. Bellati et al. Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer Ann Surg Oncol 14 2007 1136 1142
    • (2007) Ann Surg Oncol , vol.14 , pp. 1136-1142
    • Benedetti Panici, P.1    De Vivo, A.2    Bellati, F.3
  • 22
    • 34748864735 scopus 로고    scopus 로고
    • Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: Impact of surgery
    • P. Benedetti Panici, G. Perniola, and R. Angioli et al. Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery Int J Gynecol Cancer 17 2007 1245 1251
    • (2007) Int J Gynecol Cancer , vol.17 , pp. 1245-1251
    • Benedetti Panici, P.1    Perniola, G.2    Angioli, R.3
  • 23
    • 78349260017 scopus 로고    scopus 로고
    • Role of secondary cytoreductive surgery in ovarian cancer relapse: Who will benefit? A systematic analysis of 240 consecutive patients
    • J. Sehouli, R. Richter, and E.I. Braicu et al. Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients J Surg Oncol 102 2010 656 662
    • (2010) J Surg Oncol , vol.102 , pp. 656-662
    • Sehouli, J.1    Richter, R.2    Braicu, E.I.3
  • 24
    • 33845657404 scopus 로고    scopus 로고
    • Surgery in recurrent ovarian cancer - The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial
    • P. Harter, A. du Bois, and M. Hahmann et al. Surgery in recurrent ovarian cancer - the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial Ann Surg Oncol 13 2006 1702 1710
    • (2006) Ann Surg Oncol , vol.13 , pp. 1702-1710
    • Harter, P.1    Du Bois, A.2    Hahmann, M.3
  • 25
    • 78349280245 scopus 로고    scopus 로고
    • Survival after secondary cytoreduction for recurrent ovarian cancer: Which are the prognostic factors?
    • I. Biliatis, D.D. Haidopoulos, and A. Rodolakis et al. Survival after secondary cytoreduction for recurrent ovarian cancer: which are the prognostic factors? J Surg Oncol 102 2010 671 675
    • (2010) J Surg Oncol , vol.102 , pp. 671-675
    • Biliatis, I.1    Haidopoulos, D.D.2    Rodolakis, A.3
  • 26
    • 78649907488 scopus 로고    scopus 로고
    • Surgical management of recurrent ovarian cancer: The advantage of collaborative surgical management and a multidisciplinary approach
    • E. Burton, D. Chase, and M. Yamamoto et al. Surgical management of recurrent ovarian cancer: the advantage of collaborative surgical management and a multidisciplinary approach Gynecol Oncol 120 2011 29 32
    • (2011) Gynecol Oncol , vol.120 , pp. 29-32
    • Burton, E.1    Chase, D.2    Yamamoto, M.3
  • 27
    • 0018569942 scopus 로고
    • A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate
    • J.H. Goldie, and A.J. Coldman A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate Cancer Treat Rep 63 1979 1727 1733
    • (1979) Cancer Treat Rep , vol.63 , pp. 1727-1733
    • Goldie, J.H.1    Coldman, A.J.2
  • 28
    • 84866183391 scopus 로고    scopus 로고
    • The role of secondary surgery in recurrent ovarian cancer
    • 10.1155/2012/613980 [Epub 2012 Aug 5]
    • D. Lorusso, M. Mancini, and R. Di Rocco et al. The role of secondary surgery in recurrent ovarian cancer Int J Surg Oncol 2012 10.1155/2012/613980 [Epub 2012 Aug 5]
    • (2012) Int J Surg Oncol
    • Lorusso, D.1    Mancini, M.2    Di Rocco, R.3
  • 29
    • 0034941943 scopus 로고    scopus 로고
    • The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer
    • S.M. Eisenkop, and N.M. Spirtos The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer Gynecol Oncol 82 2001 143 149
    • (2001) Gynecol Oncol , vol.82 , pp. 143-149
    • Eisenkop, S.M.1    Spirtos, N.M.2
  • 30
    • 75749098037 scopus 로고    scopus 로고
    • The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: A multicenter retrospective Italian study
    • A. Gadducci, S. Cosio, and P. Zola et al. The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study Gynecol Oncol 116 2010 358 363
    • (2010) Gynecol Oncol , vol.116 , pp. 358-363
    • Gadducci, A.1    Cosio, S.2    Zola, P.3
  • 31
    • 0036074798 scopus 로고    scopus 로고
    • Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy
    • K. Fujiwara, S. Suzuki, and E. Yoden et al. Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy Int J Gynecol Cancer 12 2002 250 256
    • (2002) Int J Gynecol Cancer , vol.12 , pp. 250-256
    • Fujiwara, K.1    Suzuki, S.2    Yoden, E.3
  • 32
    • 67549118434 scopus 로고    scopus 로고
    • Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer
    • S. Fotiou, T. Aliki, and Z. Petros et al. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer Gynecol Oncol 114 2009 178 182
    • (2009) Gynecol Oncol , vol.114 , pp. 178-182
    • Fotiou, S.1    Aliki, T.2    Petros, Z.3
  • 33
    • 16644388431 scopus 로고    scopus 로고
    • Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes
    • C. Uzan, P. Morice, and A. Rey et al. Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes Ann Surg Oncol 11 2004 658 664
    • (2004) Ann Surg Oncol , vol.11 , pp. 658-664
    • Uzan, C.1    Morice, P.2    Rey, A.3
  • 34
    • 33846903602 scopus 로고    scopus 로고
    • Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer
    • A. Santillan, A.K. Karam, and A.J. Li et al. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer Gynecol Oncol 104 2007 686 690
    • (2007) Gynecol Oncol , vol.104 , pp. 686-690
    • Santillan, A.1    Karam, A.K.2    Li, A.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.